For two hundred years vaccines have been administered by intramuscular injection. Vaxart’s oral vaccine pills may change everything.
Our vaccine pills act differently, by attacking invading pathogens in the places where they first enter the body: the mucosal areas, including the mouth, the nose and the gut. They are designed to trigger strong IgA and T-cell responses to repel and overwhelm the invading viral invaders.
Vaxart has begun Phase II trials of its oral vaccine for Covid and for Norovirus– the only company in the world to reach this stage with a COVID-19 vaccine pill.
Company Details
- Employees
- 122
- Founded
- -
- Address
- 290 Utah Ave, South San Francisco,california 94080,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- vaxart.com
- Keywords
- Biotechnology and Vaccines.
- HQ
- South San Francisco, California
Vaxart, Inc. Questions
Vaxart, Inc.'s website is vaxart.com
Vaxart, Inc.'s LinkedIn profile is https://www.linkedin.com/company/vaxart
Vaxart, Inc. has
122 employees.
View email and phone details for 122
employees at Vaxart, Inc..
Vaxart, Inc.'s industry is
Biotechnology Research
Vaxart, Inc.'s top competitors are
Cargo Therapeutics,
Abbvie,
Longeveron,
Inovio Pharmaceuticals, Inc.,
Sutro Biopharma, Inc.,
Allogene Therapeutics,
Nkarta, Inc.,
Vaxcyte,
Carisma Therapeutics,
Bioatla, Inc..
Vaxart, Inc.'s categories are Biotechnology Research
Vaxart, Inc.'s founding year is 2004
